These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32386061)

  • 1. Cohort-Derived Machine Learning Models for Individual Prediction of Chronic Kidney Disease in People Living With Human Immunodeficiency Virus: A Prospective Multicenter Cohort Study.
    Roth JA; Radevski G; Marzolini C; Rauch A; Günthard HF; Kouyos RD; Fux CA; Scherrer AU; Calmy A; Cavassini M; Kahlert CR; Bernasconi E; Bogojeska J; Battegay M;
    J Infect Dis; 2021 Oct; 224(7):1198-1208. PubMed ID: 32386061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic kidney disease and HIV in the era of antiretroviral treatment: findings from a 10-year cohort study in a west African setting.
    Kaboré NF; Poda A; Zoungrana J; Da O; Ciaffi L; Semdé A; Yaméogo I; Sawadogo AB; Delaporte E; Meda N; Limou S; Cournil A
    BMC Nephrol; 2019 May; 20(1):155. PubMed ID: 31064340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of Genetic Background and Data Collection on Adverse Events of Anti-human Immunodeficiency Virus (HIV) Drugs (D:A:D) Clinical Risk Score to Chronic Kidney Disease in Swiss HIV-infected Persons With Normal Baseline Estimated Glomerular Filtration Rate.
    Dietrich LG; Barceló C; Thorball CW; Ryom L; Burkhalter F; Hasse B; Furrer H; Weisser M; Steffen A; Bernasconi E; Cavassini M; de Seigneux S; Csajka C; Fellay J; Ledergerber B; Tarr PE
    Clin Infect Dis; 2020 Feb; 70(5):890-897. PubMed ID: 30953057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study.
    Mocroft A; Lundgren JD; Ross M; Law M; Reiss P; Kirk O; Smith C; Wentworth D; Neuhaus J; Fux CA; Moranne O; Morlat P; Johnson MA; Ryom L; ; ; ; ;
    PLoS Med; 2015 Mar; 12(3):e1001809. PubMed ID: 25826420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple model for predicting incidence of chronic kidney disease in HIV-infected patients.
    Ando M; Yanagisawa N; Ajisawa A; Tsuchiya K; Nitta K
    Clin Exp Nephrol; 2011 Apr; 15(2):242-7. PubMed ID: 21246239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic kidney disease in Australian Human Immunodeficiency Virus-infected patients: Analysis of the Australian HIV Observational Database.
    Cheung J; Puhr R; Petoumenos K; Cooper DA; Woolley I; Gunathilake M; Raymond N; Varma R; O'Connor CC; Gracey DM
    Nephrology (Carlton); 2018 Aug; 23(8):778-786. PubMed ID: 28703924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primacy of lowered baseline glomerular filtration rate as a risk for incident chronic kidney disease: A longitudinal study in Japanese subjects.
    Miyakoshi T; Nakasone Y; Sato Y; Yamauchi K; Hashikura R; Takayama M; Hirabayashi K; Koike H; Moriya T; Aizawa T
    Nephrology (Carlton); 2017 Sep; 22(9):684-689. PubMed ID: 27282755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the D: A: D Chronic Kidney Disease Risk Score Model Among People Living With HIV in the Asia-Pacific.
    Han WM; Bijker R; Chandrasekaran E; Pujari S; Ng OT; Ly PS; Lee MP; Van Nguyen K; Chan YJ; Do CD; Choi JY; Chaiwarith R; Merati TP; Kiertiburanakul S; Azwa I; Khusuwan S; Zhang F; Gani YM; Tanuma J; Sangle S; Ditangco R; Yunihastuti E; Ross J; Avihingsanon A;
    J Acquir Immune Defic Syndr; 2020 Dec; 85(4):489-497. PubMed ID: 33136750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Immunosuppression on Chronic Kidney Disease in People Living With Human Immunodeficiency Virus: The D:A:D Study.
    Ryom L; Lundgren JD; Reiss P; Ross M; Kirk O; Fux CA; Morlat P; Fontas E; Smith C; De Wit S; d'Arminio Monforte A; El Sadr W; Hatleberg C; Phillips A; Sabin C; Law M; Mocroft A
    J Infect Dis; 2021 Feb; 223(4):632-637. PubMed ID: 32640015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) chronic kidney disease risk score in HIV-infected patients in the USA.
    Mills AM; Schulman KL; Fusco JS; Brunet L; Hsu R; Beyer A; Prajapati G; Mounzer K; Fusco GP
    HIV Med; 2020 May; 21(5):299-308. PubMed ID: 31985887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing tendency of urine protein is a risk factor for rapid eGFR decline in patients with CKD: A machine learning-based prediction model by using a big database.
    Inaguma D; Kitagawa A; Yanagiya R; Koseki A; Iwamori T; Kudo M; Yuzawa Y
    PLoS One; 2020; 15(9):e0239262. PubMed ID: 32941535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: the D:A:D study.
    Kamara DA; Ryom L; Ross M; Kirk O; Reiss P; Morlat P; Moranne O; Fux CA; Mocroft A; Sabin C; Lundgren JD; Smith CJ;
    BMC Nephrol; 2014 Mar; 15():51. PubMed ID: 24666792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher Prevalence and Faster Progression of Chronic Kidney Disease in Human Immunodeficiency Virus-Infected Middle-Aged Individuals Compared With Human Immunodeficiency Virus-Uninfected Controls.
    Kooij KW; Vogt L; Wit FWNM; van der Valk M; van Zoest RA; Goorhuis A; Prins M; Post FA; Reiss P;
    J Infect Dis; 2017 Sep; 216(6):622-631. PubMed ID: 28934420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study.
    Mocroft A; Lundgren JD; Ross M; Fux CA; Reiss P; Moranne O; Morlat P; Monforte Ad; Kirk O; Ryom L;
    Lancet HIV; 2016 Jan; 3(1):e23-32. PubMed ID: 26762990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of chronic kidney disease in people living with HIV by tenofovir disoproxil fumarate (TDF) use and baseline D:A:D chronic kidney disease risk score.
    Hsu R; Brunet L; Fusco J; Beyer A; Prajapati G; Wyatt C; Wohlfeiler M; Fusco G
    HIV Med; 2021 May; 22(5):325-333. PubMed ID: 33247876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic kidney disease after liver transplantation in human immunodeficiency virus/hepatitis C virus-coinfected recipients versus human immunodeficiency virus-infected recipients without hepatitis C virus: results from the National Institutes of Health multi-site study.
    Bahirwani R; Barin B; Olthoff K; Stock P; Murphy B; Rajender Reddy K;
    Liver Transpl; 2013 Jun; 19(6):619-26. PubMed ID: 23512786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the D:A:D chronic kidney disease risk score in people living with HIV: the IeDEA West Africa Cohort Collaboration.
    Poda A; Kabore NF; Malateste K; De Rekeneire N; Semde A; Bikinga Y; Patassi A; Chenal H; Messou E; Dabis F; Ekouevi DK; Jaquet A; Cournil A
    HIV Med; 2021 Feb; 22(2):113-121. PubMed ID: 33145918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of estimated glomerular filtration rates using Cockcroft-Gault and the Chronic Kidney Disease Epidemiology Collaboration estimating equations in HIV infection.
    Mocroft A; Ryom L; Reiss P; Furrer H; D'Arminio Monforte A; Gatell J; de Wit S; Beniowski M; Lundgren JD; Kirk O;
    HIV Med; 2014 Mar; 15(3):144-52. PubMed ID: 24118916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of kidney disease outcomes with risk factors for CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study.
    Yang W; Xie D; Anderson AH; Joffe MM; Greene T; Teal V; Hsu CY; Fink JC; He J; Lash JP; Ojo A; Rahman M; Nessel L; Kusek JW; Feldman HI;
    Am J Kidney Dis; 2014 Feb; 63(2):236-43. PubMed ID: 24182662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Kidney Failure Risk Equation for prediction of end stage renal disease in UK primary care: An external validation and clinical impact projection cohort study.
    Major RW; Shepherd D; Medcalf JF; Xu G; Gray LJ; Brunskill NJ
    PLoS Med; 2019 Nov; 16(11):e1002955. PubMed ID: 31693662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.